Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endonovo Therapeutics Inc (ENDV)

Endonovo Therapeutics Inc (ENDV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board

via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Appoints Dr. Steven Levin of Johns Hopkins University to Its Scientific Advisory Board

via NetworkWire - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0121 (-0.82%)
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire

via NetworkWire -- Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company developing a bioelectronic approach to regenerative medicine, today announces it has selected the corporate communications...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics and Veterans Healthcare Supply Solutions Announce Distribution Agreement

Endonovo Therapeutics, Inc. (OTCQB: ENDV) and Veterans Healthcare Supply Solutions Inc. (VHSS) today announced a long-term agreement encompassing the distribution of SofPulse(R) to Veterans Administration...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, that Roc Alan McCarthy, D.O. will be joining the company as a Scientific Advisory Board Member. Dr. McCarthy will help Endonovo continue to advance...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Announces Steven Ford as V.P. Marketing

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, Steven Ford will be joining the company as Vice President of Marketing. In his position, Mr. Ford will be responsible for growing Endonovo's...

AGN : 163.16 (+0.68%)
ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Hires David Clark as Vice President of Sales

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced veteran sales leader David Clark joined as Endonovo's Vice President of Sales. In his new position, Mr. Clark will lead the U.S. Sales Team, distributors...

ENDV : 0.0121 (-0.82%)
MDT : 100.80 (-0.53%)
Endonovo Therapeutics Hires Nevena Zubcevik of Harvard Medical School as Chief Medical Officer

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced the appointment of Nevena Zubcevik, DO, MSPT, ATC as its chief medical officer starting July 1, 2019.

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Provides Corporate Update

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announced a corporate update and business...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Announces Partnership with Second Hospital

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announced an agreement with a nationally recognized hospital group to enhance the quality of the healthcare/patient experience...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Granted Trademarks for WoundPulse and OrthoHalo

March 22, 2019 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapies brand, today announced the U.S. Patent...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Partners with SunMED Medical Systems

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"),

MDSY : 0.73 (+4.29%)
ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Announces New Website Launch

The completely redesigned website offers visitors deeper insight into the Company's core product, SofPulse(R)

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Files Lawsuit against KVP International Inc., Orthocor Medical Inc., and Careus Corp. for Patent Infringement

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, filed a patent infringement lawsuit today...

ENDV : 0.0121 (-0.82%)
Innovative Developments in Biotechnology set to Spur the Market Growth

NEW YORK, January 23, 2019 /PRNewswire/ --

NMUS : 0.6500 (-9.52%)
PMCB : 0.0385 (-4.23%)
ENDV : 0.0121 (-0.82%)
SNET : 0.0103 (+63.49%)
ATBPF : 0.2470 (+1.35%)
Endonovo Therapeutics Issues Shareholder Letter and Update

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announced the issuance of the following...

ENDV : 0.0121 (-0.82%)
The Next Big Biotech Breakout

HENDERSON, NV / ACCESSWIRE / January 8, 2019 / Celgene's major deal with Bristol-Myers Squibb seems to have woken up the sleeping giant that is the biotech market. Axsome announced positive trial data...

GNMX : 0.19 (-6.45%)
ENDV : 0.0121 (-0.82%)
CELGZ : 0.47 (-5.98%)
HSGX : 0.20 (unch)
BMY : 43.33 (-1.63%)
AXSM : 24.85 (-1.78%)

Van Meerten Stock Picks

Leading Economic Indicator ALERT!
I very closely follow the Conference Board's Leading Economic Indicators.
IVV -1.75
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar